Nakornthon Hospital Public Company Limited

NKT · BK · Healthcare / Medical Care Facilities

3.68THB-0.02 (-0.54%)

Price History

Full chart

Market Stats

Previous Close3.70

Open3.70

Day Range3.68 – 3.72

52-Week Range3.62 – 4.15

Volume141.30K

Market Cap1.97B

P/E (TTM)17.52

Forward P/E0.00

EPS0.21

Dividend Yield4.89%

50-Day Avg3.70

200-Day Avg3.92

About

Nakornthon Hospital Public Company Limited, together with its subsidiaries, operates a hospital that provides various medical services in Thailand. It offers centers for cancer, spine, orthopedics, rainbow services, pain management care, geriatric care, gastrointestinal and liver, neurology, children health, internal medicine, fertility, heart, wellness, aesthetics and skin, surgery, rehabilitation, eyes, women health, ears, nose, throat, breast, dental, allergy and immunology care, breastfeeding care, hemodialysis, emergency medicine, and medical imaging. The company is also involved in elderly and dependent care center. Nakornthon Hospital Public Company Limited was incorporated in 1993 and is based in Bangkok, Thailand.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEODr. Wisan Saiphet
Employees0
HeadquartersNakornthon Hospital, Bangkok, Thailand, 10150, Thailand
Websitehttps://www.nakornthon.com

Leadership

Associate Prof. Yandhet ThongsimaPresident & Chairman of the Board · b. 1948
Dr. Wisan SaiphetChief Executive Officer · b. 1952
Ms. Yaowaret ThongsimaDirector of Administration & Executive Director · b. 1969
Ms. Supawadee LoikaewDirector of Finance & Accounting · b. 1979
Mr. Simathong ThongsimaChief Administrative Officer · b. 1985
Ms. Pensiri ThongsimaDirector of Marketing & Business Development · b. 1979
Prof. Wiroj KawinwonggowitDeputy Chief Executive Officer · b. 1956
Dr. Siremorn ThongsimaMedical Director & Director · b. 1981
Mr. Piyadet ThongsimaExecutive Director · b. 1983
Ms. Thanattorn ThongsimaCompany Secretary · b. 1988

Financials

Income Statement

Currency: THB	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.94B	2.00B	1.99B	1.99B
Growth (%)	-	+3.43%	-0.88%	+0.02%
Cost of Revenue	1.31B	1.39B	1.40B	1.42B
Gross Profit	630.11M	617.80M	585.38M	564.41M
Gross Margin	32.53%	30.83%	29.48%	28.41%
Operating Expense	231.32M	259.92M	288.45M	306.20M
Operating Income	398.79M	357.88M	296.94M	258.21M
Operating Margin	20.59%	17.86%	14.95%	13.00%
EBITDA	505.74M	491.14M	428.50M	394.03M
EBITDA Margin	26.11%	24.51%	21.58%	19.84%
Net Income	320.91M	282.29M	233.70M	195.35M
Net Income Margin	16.57%	14.09%	11.77%	9.83%
Interest Expense	8.62K	4.82M	11.69M	5.60M
Interest Expense % of Total Revenue	0.00%	0.24%	0.59%	0.28%

Balance Sheet

Currency: THB	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.80B	2.01B	2.62B	2.61B
Total Liabilities	435.82M	467.07M	693.27M	587.89M
Total Equity	1.37B	1.55B	1.93B	2.02B
Cash	90.71M	198.31M	1.09B	299.10M

Cash Flow

Currency: THB	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	454.29M	381.46M	352.86M	380.56M
Financing Cash Flow	-44.08M	-99.97M	297.35M	-244.75M
Capital Expenditure	244.63M	174.85M	248.86M	932.37M
Free Cash Flow	209.66M	206.61M	103.99M	-551.81M
Dividends Paid	43.77M	99.97M	873.96M	94.75M
FCF to OCF	46.15%	54.16%	29.47%	-145.00%
Dividend Paid to FCF	20.88%	48.39%	840.40%	-17.17%

Earnings

Report Date	Feb 20, 2025	May 8, 2025	Sep 3, 2025	Dec 18, 2025	Feb 25, 2026	May 14, 2026	Aug 12, 2026
EPS Estimate	-	-	-	-	-	-	-
EPS Actual	0.08	0.10	0.08	0.12	0.06	0.01	0.02
Surprise	-	-	-	-	-	-	-
Timing	Pre-market	Pre-market	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.97B

Enterprise Value2.14B

Trailing P/E17.52

Forward P/E0.00

Price / Sales0.97

Price / Book1.02

EPS0.21

Book Value3.63

Revenue (TTM)2.02B

Gross Profit (TTM)541.93M

EBITDA326.97M

Profit Margin5.75%

Operating Margin5.49%

Return on Equity6.01%

Return on Assets4.24%

Shares Outstanding535.00M

Shares Float238.66M

Dividend Yield4.89%

Dividend Rate0.18

Payout Ratio82.80%

Dividends

20261×

0.18May 7, 2026

20251×

0.18May 6, 2025